Logo image of AMRQ.CA

AMAROQ LTD (AMRQ.CA) Stock Fundamental Analysis

Canada - TSX-V:AMRQ - CA02311U1030 - Common Stock

1.57 CAD
+0.1 (+6.8%)
Last: 10/6/2025, 7:00:00 PM
Fundamental Rating

3

AMRQ gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 818 industry peers in the Metals & Mining industry. AMRQ scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. AMRQ is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year AMRQ has reported negative net income.
In the past year AMRQ has reported a negative cash flow from operations.
In the past 5 years AMRQ always reported negative net income.
In the past 5 years AMRQ always reported negative operating cash flow.
AMRQ.CA Yearly Net Income VS EBIT VS OCF VS FCFAMRQ.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

The Return On Assets of AMRQ (-8.63%) is better than 63.57% of its industry peers.
Looking at the Return On Equity, with a value of -10.78%, AMRQ is in the better half of the industry, outperforming 64.30% of the companies in the same industry.
Industry RankSector Rank
ROA -8.63%
ROE -10.78%
ROIC N/A
ROA(3y)-14.53%
ROA(5y)-24%
ROE(3y)-15.86%
ROE(5y)-25.71%
ROIC(3y)N/A
ROIC(5y)N/A
AMRQ.CA Yearly ROA, ROE, ROICAMRQ.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400 -500

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for AMRQ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AMRQ.CA Yearly Profit, Operating, Gross MarginsAMRQ.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

4

2. Health

2.1 Basic Checks

The number of shares outstanding for AMRQ has been increased compared to 1 year ago.
Compared to 5 years ago, AMRQ has more shares outstanding
Compared to 1 year ago, AMRQ has an improved debt to assets ratio.
AMRQ.CA Yearly Shares OutstandingAMRQ.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
AMRQ.CA Yearly Total Debt VS Total AssetsAMRQ.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 5.83 indicates that AMRQ is not in any danger for bankruptcy at the moment.
AMRQ has a Altman-Z score of 5.83. This is in the better half of the industry: AMRQ outperforms 60.51% of its industry peers.
A Debt/Equity ratio of 0.15 indicates that AMRQ is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.15, AMRQ is not doing good in the industry: 64.79% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z 5.83
ROIC/WACCN/A
WACCN/A
AMRQ.CA Yearly LT Debt VS Equity VS FCFAMRQ.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

AMRQ has a Current Ratio of 1.98. This is a normal value and indicates that AMRQ is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of AMRQ (1.98) is comparable to the rest of the industry.
AMRQ has a Quick Ratio of 1.73. This is a normal value and indicates that AMRQ is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of AMRQ (1.73) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.98
Quick Ratio 1.73
AMRQ.CA Yearly Current Assets VS Current LiabilitesAMRQ.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 12.79% over the past year.
EPS 1Y (TTM)12.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-197.9%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, AMRQ will show a very strong growth in Earnings Per Share. The EPS will grow by 68.15% on average per year.
The Revenue is expected to grow by 285.10% on average over the next years. This is a very strong growth
EPS Next Y193.07%
EPS Next 2Y96.5%
EPS Next 3Y68.15%
EPS Next 5YN/A
Revenue Next Year3499.53%
Revenue Next 2Y578.62%
Revenue Next 3Y285.1%
Revenue Next 5YN/A

3.3 Evolution

AMRQ.CA Yearly Revenue VS EstimatesAMRQ.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2023 2024 2025 2026 2027 50M 100M 150M
AMRQ.CA Yearly EPS VS EstimatesAMRQ.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2023 2024 2025 2026 2027 0 0.05 -0.05 0.1 0.15

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AMRQ. In the last year negative earnings were reported.
AMRQ is valuated correctly with a Price/Forward Earnings ratio of 14.05.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AMRQ indicates a rather cheap valuation: AMRQ is cheaper than 91.69% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of AMRQ to the average of the S&P500 Index (23.36), we can say AMRQ is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 14.05
AMRQ.CA Price Earnings VS Forward Price EarningsAMRQ.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AMRQ.CA Per share dataAMRQ.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AMRQ's earnings are expected to grow with 68.15% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y96.5%
EPS Next 3Y68.15%

0

5. Dividend

5.1 Amount

AMRQ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AMAROQ LTD

TSX-V:AMRQ (10/6/2025, 7:00:00 PM)

1.57

+0.1 (+6.8%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-14 2025-08-14
Earnings (Next)11-14 2025-11-14
Inst Owners25.32%
Inst Owner ChangeN/A
Ins Owners5.93%
Ins Owner ChangeN/A
Market Cap712.95M
Analysts84
Price Target128.52 (8085.99%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)154.65%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)23.31%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.05
P/S 206.93
P/FCF N/A
P/OCF N/A
P/B 2.6
P/tB 2.6
EV/EBITDA N/A
EPS(TTM)-0.08
EYN/A
EPS(NY)0.11
Fwd EY7.12%
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.01
BVpS0.6
TBVpS0.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.63%
ROE -10.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-14.53%
ROA(5y)-24%
ROE(3y)-15.86%
ROE(5y)-25.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 10486.3%
Cap/Sales 3026.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.98
Quick Ratio 1.73
Altman-Z 5.83
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)5033.11%
Cap/Depr(5y)3667.36%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-197.9%
EPS Next Y193.07%
EPS Next 2Y96.5%
EPS Next 3Y68.15%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year3499.53%
Revenue Next 2Y578.62%
Revenue Next 3Y285.1%
Revenue Next 5YN/A
EBIT growth 1Y-5.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2117.85%
EBIT Next 3Y367.44%
EBIT Next 5YN/A
FCF growth 1Y-359.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y78.89%
OCF growth 3YN/A
OCF growth 5YN/A